Your browser doesn't support javascript.
loading
Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
Gravel, Caroline; Elmgren, Cathie; Muralidharan, Abenaya; Hashem, Anwar M; Jaentschke, Bozena; Xu, Kangwei; Widdison, Jennifer; Arnold, Kristin; Farnsworth, Aaron; Rinfret, Aline; Van Domselaar, Gary; Wang, Junzhi; Li, Changgui; Li, Xuguang.
Afiliación
  • Gravel C; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.
  • Elmgren C; Canadian Food Inspection Agency, Ottawa, ON, Canada.
  • Muralidharan A; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Hashem AM; Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Jaentschke B; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.
  • Xu K; National Institutes for the Control of Food and Drug and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, PR China.
  • Widdison J; Canadian Food Inspection Agency, Ottawa, ON, Canada.
  • Arnold K; Canadian Food Inspection Agency, Ottawa, ON, Canada.
  • Farnsworth A; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.
  • Rinfret A; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.
  • Van Domselaar G; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • Wang J; National Institutes for the Control of Food and Drug and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, PR China.
  • Li C; National Institutes for the Control of Food and Drug and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, PR China.
  • Li X; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada. Electroni
Vaccine ; 33(9): 1129-34, 2015 Feb 25.
Article en En | MEDLINE | ID: mdl-25620245
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Immunoblotting / Epítopos de Linfocito B / Glicoproteínas Hemaglutininas del Virus de la Influenza / Subtipo H7N9 del Virus de la Influenza A / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Evaluation_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2015 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Immunoblotting / Epítopos de Linfocito B / Glicoproteínas Hemaglutininas del Virus de la Influenza / Subtipo H7N9 del Virus de la Influenza A / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Evaluation_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2015 Tipo del documento: Article País de afiliación: Canadá